These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 35042318)
1. Methotrexate in inflammatory bowel disease: A primer for gastroenterologists. AlAmeel T; Al Sulais E; Raine T Saudi J Gastroenterol; 2022; 28(4):250-260. PubMed ID: 35042318 [TBL] [Abstract][Full Text] [Related]
2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279 [TBL] [Abstract][Full Text] [Related]
3. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment? Sedano Muñoz R; Quera Pino R; Ibáñez Lazo P; Figueroa Corona C; Flores Pérez L Gastroenterol Hepatol; 2019 May; 42(5):339-347. PubMed ID: 30954317 [TBL] [Abstract][Full Text] [Related]
4. Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease. Johnson CM; Dassopoulos T Curr Gastroenterol Rep; 2018 Sep; 20(11):53. PubMed ID: 30267281 [TBL] [Abstract][Full Text] [Related]
5. Experience with the use of low-dose methotrexate for inflammatory bowel disease. Soon SY; Ansari A; Yaneza M; Raoof S; Hirst J; Sanderson JD Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):921-6. PubMed ID: 15316419 [TBL] [Abstract][Full Text] [Related]
6. Newer treatments for inflammatory bowel disease. Stotland BR; Lichtenstein GR Prim Care; 1996 Sep; 23(3):577-608. PubMed ID: 8888346 [TBL] [Abstract][Full Text] [Related]
7. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
8. [The use of methotrexate in an inflammatory bowel diseases based on the review of the current literature]. Klimczak K; Łykowska-Szuber L; Krela-Kaźmierczak I; Eder P; Szymczak A; Stawczyk-Eder K; Linke K Wiad Lek; 2016; 69(2 Pt 2):262-6. PubMed ID: 27487545 [TBL] [Abstract][Full Text] [Related]
9. IOIBD questionnaire on the clinical use of azathioprine, 6-mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases. Meuwissen SG; Ewe K; Gassull MA; Geboes K; Jewell D; Pallone F; Rachmilewitz D; Rask-Madsen J; Riddell BH; Sandborn BJ; Schmuck ML Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):13-8. PubMed ID: 10656204 [TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. Markowitz J; Grancher K; Mandel F; Daum F Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272 [TBL] [Abstract][Full Text] [Related]
11. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary. Hanauer SB; Sandborn WJ; Lichtenstein GR Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449 [TBL] [Abstract][Full Text] [Related]
12. Review article: monitoring of immunomodulators in inflammatory bowel disease. Aberra FN; Lichtenstein GR Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982 [TBL] [Abstract][Full Text] [Related]
13. Drug resistance in inflammatory bowel diseases. Moreau J; Mas E Curr Opin Pharmacol; 2015 Dec; 25():56-61. PubMed ID: 26645664 [TBL] [Abstract][Full Text] [Related]
14. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of thiopurines in inflammatory bowel disease. Bermejo F; Aguas M; Chaparro M; Domènech E; Echarri A; García-Planella E; Guerra I; Gisbert JP; López-Sanromán A; Gastroenterol Hepatol; 2018 Mar; 41(3):205-221. PubMed ID: 29357999 [TBL] [Abstract][Full Text] [Related]
15. Low dose methotrexate in inflammatory bowel disease: current status and future directions. Schröder O; Stein J Am J Gastroenterol; 2003 Mar; 98(3):530-7. PubMed ID: 12650783 [TBL] [Abstract][Full Text] [Related]
16. Recent advances in immunomodulation in the treatment of inflammatory bowel disease. Travis S Eur J Gastroenterol Hepatol; 2003 Mar; 15(3):215-8. PubMed ID: 12610313 [TBL] [Abstract][Full Text] [Related]